TITLE

Nonsynonymous variants and fatty liver disease

AUTHOR(S)
Mohlke, Karen L.
PUB. DATE
December 2008
SOURCE
Nature Genetics;Dec2008, Vol. 40 Issue 12, p1394
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Fat accumulation in the liver is a common trait that may progress to severe liver disease. A new study identifies common and rare nonsynonymous variants in PNPLA3 that are associated with hepatic triglyceride content and that may explain some of the population differences in prevalence.
ACCESSION #
35387462

 

Related Articles

  • Genetic Susceptibility to Hepatic Steatosis. Diehl, Anna Mae // New England Journal of Medicine;3/25/2010, Vol. 362 Issue 12, p1142 

    The author claims that steatosis or the accumulation of triglycerides in the liver is a highly prevalent condition affecting close to one third of adults in the U.S. as of March 2010. She says that steatosis is linked with increased mortality due to liver disease, cancer and cardiovascular...

  • Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. Kawano, Yuki; Cohen, David // Journal of Gastroenterology;Apr2013, Vol. 48 Issue 4, p434 

    Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic lipid accumulation in the absence of excess alcohol intake. NAFLD is the most common chronic liver disease, and ongoing research efforts are focused on understanding the underlying pathobiology of hepatic steatosis with the...

  • Nonalcoholic Fatty Liver Disease. Angulo, Paul // New England Journal of Medicine;4/18/2002, Vol. 346 Issue 16, p1221 

    Presents information on nonalcoholic fatty liver disease. Description of the disease; Symptoms, including obesity and type 2 diabetes mellitus; Prevalence of the disease; Way that the disease manifests itself; How the disease is diagnosed.

  • Non-alcoholic fatty liver disease in Japanese patients.  // Clinical Cardiology Alert;Apr2010 Primary Care Supplement, Vol. 15 Issue 4, p8 

    The article discusses research on the histological course of nonalcoholic fatty liver disease in Japanese patients, which references a study by E. Hamaguchi and colleagues published in a 2010 issue of "Diabetes Care."

  • Nonalcoholic Fatty Liver Disease (NAFLD) in Saudi Patients with T2DM in Jazan Region: Prevalence and Associated Factors. Elmakki, Erwa; Aqeely, Hussein; Bani, Ibrahim; Omer, Husam; Solan, Yahya; Taher, Asim; Hadi, Talal; Mohammed, Musa; Abdalla, Saif Elden; Mahfouz, Mohammed S.; Tsan Yang // British Journal of Medicine & Medical Research;2015, Vol. 5 Issue 7, p878 

    Backgrounds: Non-alcoholic fatty liver disease (NAFLD) has become one of the major health problems world widely, especially among communities with sedentary lifestyle. The main objectives of this study were to know the prevalence of NAFLD among Saudi patients with T2DM in Jazan region and to...

  • Increased Acylation Stimulating Protein Concentrations in Nonalcoholic Fatty Liver Disease are Associated with Insulin Resistance. Yesilova, Zeki; Ozata, Metin; Oktenli, Cagatay; Bagci, Sait; Ozcan, Ayhan; Sanisoglu, S. Yavuz; Uygun, Ahmet; Yaman, Halil; Karaeren, Necmettin; Dagalp, Kemal // American Journal of Gastroenterology;Apr2005, Vol. 100 Issue 4, p842 

    OBJECTIVES: As acylation stimulating protein (ASP) acts on adipocytes mainly as a paracrine factor to increase triglyceride synthesis and storage; hypothetically, it may play a similar role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).METHODS: Forty-six male patients with...

  • Non-alkolik yaÄŸlı karaciÄŸer hastalığında asimetrik dimetil arjinin ve karotis intima-mediya kalınlığı ile hemoglobin düzeylerinin karşılaÅŸtırılması Kara, Muammer; Genç, Halil; Doğru, Teoman; Bağcı, Sait // Gulhane Medical Journal;Mar2012, Vol. 54 Issue 1, p40 

    There are controversial results about studies investigating the relationship between non-alcholic fatty liver disease and the risk of cardiovascular disease. In studies performed in different patient series it has been shown that the risk of cardiovascular disease has increased in patients with...

  • Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass. Knebel, Birgit; Haas, Jutta; Hartwig, Sonja; Jacob, Sylvia; K�llmer, Cornelia; Nitzgen, Ulrike; Muller-Wieland, Dirk; Kotzka, Jorg // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    The pathogenesis of fatty liver is not understood in detail, but lipid overflow as well as de novo lipogenesis (DNL) seem to be the key points of hepatocyte accumulation of lipids. One key transcription factor in DNL is sterol regulatory elementbinding protein (SREBP)-1c. We generated mice with...

  • A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies. Catta-Preta, Mariana; Mendonca, Leonardo; Fraulob-Aquino, Julio; Aguila, Marcia; Mandarim-de-Lacerda, Carlos; Mendonca, Leonardo Souza; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto // Virchows Archiv;Nov2011, Vol. 459 Issue 5, p477 

    The issue of adequately quantitatively evaluating hepatic steatosis is still unresolved. Therefore, we compared three methods of quantitative assessment. Two groups of mice (n = 10 each) were fed standard chow (10% fat, SC group) or a high-fat diet (60% fat, HF group) for 16 weeks,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics